Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Igor Radanovic"'
Autor:
Igor Radanovic, Naomi Klarenbeek, Robert Rissmann, Geert Jan Groeneveld, Emilie M. J. van Brummelen, Matthijs Moerland, Jacobus J. Bosch
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimTraditionally, early phase clinical trials in oncology have been performed in patients based on safety risk-benefit assessment. Therapeutic transition to immuno-oncology may open new opportunities for studies in healthy volunteers, which are condu
Externí odkaz:
https://doaj.org/article/05c5b23e725044ca9151f80660d82f26
Autor:
Hui Jing Yu, Eva Thijssen, Emilie van Brummelen, Johan L. van der Plas, Igor Radanovic, Matthijs Moerland, Eric Hsieh, Geert Jan Groeneveld, Jean‐Cosme Dodart
Publikováno v:
Movement Disorders. 37:1416-1424
α-Synuclein (αSyn) is believed to play a central role in Parkinson's disease (PD) neuropathology and is considered a target for disease modification. UB-312 is a synthetic αSyn peptide conjugated to a T helper peptide and is expected to induce ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d6d6b86be0d0253b34c57147c3d383
https://doi.org/10.1002/mds.29016
https://doi.org/10.1002/mds.29016
Publikováno v:
Reviews in medical virologyREFERENCES. 32(6)
Intravenous immunoglobulin (IVIg) therapy has been suggested as a potential treatment option for hospitalised COVID-19 patients. The aim of this systematic review and meta-analysis was to investigate the potential impact of IVIg on mortality and leng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba70180fac976bdfc53bf2f1cfe1993
https://pubmed.ncbi.nlm.nih.gov/36097650
https://pubmed.ncbi.nlm.nih.gov/36097650